Published in J Exp Med on December 01, 1969
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest (1973) 4.57
Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia. J Clin Invest (1971) 3.06
Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med (1974) 2.45
Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun (1979) 2.07
Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol (1983) 1.85
Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells. J Cell Biol (1978) 1.66
The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology (1977) 1.59
Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis. Am J Pathol (1972) 1.51
Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest (1974) 1.44
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
The role of complement in the induction of antibody responses. Clin Exp Immunol (1983) 1.16
The structural requirements for immunoglobulin aggregates to localize in germinal centres. Immunology (1978) 1.03
Immunopathologic aspects of woodchuck hepatitis. Am J Pathol (1984) 0.98
Complement activation in human lymphoid germinal centres. Immunology (1989) 0.95
Lymphocyte binding of fluid phase mouse C3b. Immunology (1979) 0.93
Immune complexes in the spleen. The difference between competitive inhibition of immune complex trapping in spleen follicles and inhibition by paratyphoid vaccine. Immunology (1975) 0.89
The role of complement in the induction and regulation of immune responses. Immunology (1984) 0.84
Hematogenous Streptococcus faecalis pyelonephritis in the rat. A histologic, immunopathologic and bacteriologic study. Am J Pathol (1974) 0.81
Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant. Infect Immun (1982) 0.75
Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice. Immunology (2004) 0.75
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 31.27
Localization of antigen in tissue cells; cellular distribution of pneumococcal polysaccharides types II and III in the mouse. J Exp Med (1950) 11.51
Localization of antigen in tissue cells. VI. The fate of injected foreign proteins in the mouse. J Exp Med (1951) 10.90
Chromatographic purification of tetramethylrhodamine-immune globulin conjugates and their use in the cellular localization of rabbit gamma-globulin polypeptide chains. J Immunol (1965) 8.88
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med (1965) 8.31
Antibody formation in vitro. J Exp Med (1961) 7.49
MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol (1965) 7.06
Studies on antibody production. II. The primary and secondary responses in the popliteal lymph node of the rabbit. J Exp Med (1955) 6.56
Fluorescent antibody staining. 3. Preparation of fluorescein-isothiocyanate-labeled antibodies. J Immunol (1965) 5.82
Cellular sites of formation of gamma globulin. J Exp Med (1957) 4.68
RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM. J Exp Med (1960) 4.66
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
THE CELLULAR ORIGIN OF HUMAN IMMUNOGLOBULINS (GAMMA-2, GAMMA-1M, GAMMA-1A). J Exp Med (1963) 4.48
Antigenic determinants of human beta-1c and beta-1g-globulins. J Immunol (1966) 4.22
ANTIGENS IN IMMUNITY. IV. CELLULAR LOCALIZATION OF 125-I- AND 131-I-LABELLED FLAGELLA IN LYMPH NODES. Aust J Exp Biol Med Sci (1964) 4.00
ANTIGENS IN IMMUNITY. V. THE ABILITY OF CELLS IN LYMPHOID FOLLICLES TO RECOGNIZE FOREIGNNESS. Aust J Exp Biol Med Sci (1964) 3.27
The localization of antigen in relation to specific antibody-producing cells. I. Use of a synthetic polypeptide [(T,G)-A--L] labelled with iodine-125. Immunology (1966) 3.09
Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis. Immunology (1967) 2.93
ANTIGENS IN IMMUNITY. VI. THE PHAGOCYTIC RETICULUM OF LYMPH NODE FOLLICLES. J Exp Med (1964) 2.90
Ultrastructure of the antigen-retaining reticulum of lymph node follicles as shown by high-resolution autoradiography. Nature (1965) 2.76
PREPARATION AND PROPERTIES OF THE PEPTIDE CHAINS OF NORMAL HUMAN 19 S GAMMA-GLOBULIN (IGM). Biochem J (1965) 2.27
CELL PROLIFERATION IN GERMINAL CENTERS OF THE RAT SPLEEN. Ann N Y Acad Sci (1964) 2.27
Gamma globulin and molecular mechanisms in hypersensitivity reactions. Prog Allergy (1963) 2.10
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Polypeptide chain structure of rabbit immunoglobulins. I. gamma-G-immunoglobulin. Biochemistry (1966) 2.00
Sites of synthesis of serum proteins. OI. Serum proteins produced by macrophages in vitro. J Immunol (1967) 1.96
The histophysiology of the antibody response. I. Histogenesis of the plasma cell reaction in rabbit spleen. Lab Invest (1963) 1.93
Sites of production of primate serum proteins associated with complement system. Proc Soc Exp Biol Med (1967) 1.88
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83
THE FINE STRUCTURE OF THE LYMPHOID TISSUE DURING ANTIBODY FORMATION. Exp Mol Pathol (1965) 1.68
AN AUTORADIOGRAPHIC STUDY OF THE GERMINAL CENTER IN SPLEEN WHITE PULP DURING EARLY INTERVALS OF THE IMMUNE RESPONSE. Lab Invest (1964) 1.62
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Beta-1C and immune globulin formation in vitro by tissues from germ-free and conventional rodents of various ages. Immunology (1967) 1.52
GERMINAL CENTER CHANGES AND PLASMA CELL REACTION DURING THE PRIMARY IMMUNE RESPONSE. Int Arch Allergy Appl Immunol (1965) 1.52
Sites of synthesis of serum proteins. 3. Production of beta-1-C, beta-1-E and transferrin by primate and rodent cell lines. J Immunol (1967) 1.46
INCORPORATION OF TRITIATED NUCLEOSIDES AND AMINO ACIDS INTO LYMPHOID AND PLASMOCYTOID CELLS DURING SECONDARY RESPONSE TO TETANUS TOXOID IN MICE. Ann N Y Acad Sci (1964) 1.45
Heterogeneity of antibody-forming cells. An electron microscopic analysis. J Exp Med (1969) 1.35
ANTIGENS IN IMMUNITY. XI. THE UPTAKE OF ANTIGEN IN ANIMALS PREVIOUSLY RENDERED IMMUNOLOGICALLY TOLERANT. Aust J Exp Biol Med Sci (1965) 1.32
STUDIES ON IN VITRO ANTIBODY PRODUCTION. 3. PRODUCTION OF COMPLEMENT. Can J Microbiol (1965) 1.26
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): II. PRODUCTION OF IMMUNOELECTROPHORETICALLY IDENTIFIED SERUM PROTEINS BY HUMAN AND MONKEY TISSUES IN VITRO. J Exp Med (1961) 1.17
Synthesis of B1c-B1a-globulin (C'3) by human lymphoid cells. Int Arch Allergy Appl Immunol (1968) 1.12
Relationship of germinal centers in lymphoid tissue to immunological memory. II. The detection of primed cells and their proliferation upon cell transfer to lethally irradiated syngeneic mice. J Exp Med (1968) 1.08
Gamma-globulin and antibody formation in vitro. V. The secondary response made by splenic white and red pulp with reference to the role of secondary nodules. J Immunol (1966) 1.07
The role of immune complexes and complement in tissue injury. J Allergy (1968) 1.04
Development and function of the immunoglobulin-producing system. II. Role of the bursa in the development of humoral immunological competence. J Immunol (1969) 0.90
Effect of antigen dose on lymphatic tissue germinal center changes. Proc Soc Exp Biol Med (1966) 0.89
Morphologic changes in spleen lymphatic tissue during antibody production. Exp Mol Pathol (1966) 0.86
Sites of synthesis of serum proteins. II. Medium requirements for serum protein production by rat macrophages. J Immunol (1967) 0.84
Models of immunologic diseases and disorders. Fed Proc (1969) 0.82
[Secondary lymphoid nodules]. Nouv Rev Fr Hematol (1965) 0.80
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01
Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet (1972) 9.01
Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis (1995) 6.95
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41
Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89
Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64
Definition of staphylococcal protein A reactivity for human immunoglobulin G fragments. Immunochemistry (1970) 2.61
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52
A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res (1981) 2.39
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37
Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33
NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32
Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31
Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31
The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats. J Clin Invest (1972) 2.26
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect. Lancet (1967) 2.19
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973. J Pediatr (1975) 2.15
Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03
Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99
Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96
Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94
Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94
Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79
Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77
Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76
Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75
Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats. Nature (1971) 1.74
N.B.T. test stimulated. Lancet (1970) 1.73
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood (1988) 1.72
B and T lymphocytes in primary immunodeficiency disease in man. J Clin Invest (1973) 1.72
Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A (1976) 1.71
Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia. Lancet (1972) 1.71
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med (1978) 1.64
Complement and complement-like activity in lower vertebrates and invertebrates. J Exp Med (1970) 1.61
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A (1999) 1.61
Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.60
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59
Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci U S A (1979) 1.59
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Age, thymic involution, and circulating thymic hormone activity. J Clin Endocrinol Metab (1978) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Dyschondrosteosis. The most common cause of Madelung's deformity. J Pediatr (1966) 1.57
Complement-dependent biological functions in complement deficiency in man. Lancet (1966) 1.56
Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol (1992) 1.56